Conditions: Hidradenitis Suppurativa
Keywords: hidradenitis suppurativa anakinra
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 6
Healthy volunteers: no

Brief summary:
This is an open-label, proof-of-concept research study to assess the effectiveness of anakinra in the treatment of patients with hidradenitis suppurativa (HS). The planned intervention is to provide about 6 HS patients with anakinra 100mg daily injections to administer subcutaneously for 8 weeks. Then, the study subjects will be followed for a further 8 weeks to monitor for relapse of HS.

Detailed description:

Arms:
arm 1: All patients in this arm will receive the investigation drug anakinra once daily subcutaneously.

Interventions: intervention 1: anakinra
Intervention descriptions: intervention 1: Anakinra is supplied in individual pre-filled glass syringes 100mg/0.67mL each. It will be injected subcutaneously once daily for 8 continuous weeks.

Protocol document: